Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Biliary Tract Neoplasms 3Breast Neoplasms 2Uterine Neoplasms 1Sarcoma, Ewing 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Lobular 1

Interventions

Fulvestrant 63Letrozole 53Paclitaxel 49Trastuzumab 41pembrolizumab 40ribociclib 37Specimen Handling 37palbociclib 36Capecitabine 34Carboplatin 33Anastrozole 33Tamoxifen 32exemestane 29pertuzumab 28abemaciclib 28Magnetic Resonance Spectroscopy 26Cyclophosphamide 26trastuzumab deruxtecan 24Surveys and Questionnaires 21Radiotherapy 18Biopsy 18olaparib 17Standard of Care 16Docetaxel 16Blood Specimen Collection 16Taxes 14Mastectomy, Segmental 14eribulin 13elacestrant 13130-nm albumin-bound paclitaxel 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Breast Neoplasms × Liquid Biopsy × 90 days × Clear all
NCT06268405 2026-04-29

Positron Emission Mammography and Liquid Biopsy in Women With High-risk Breast Screenings

University Health Network, Toronto

Phase NA Recruiting
100 enrolled
Breast

Breast Neoplasms

NCT06067503 2026-04-13

Biomarkers to Detect Endocrine Therapy Resistance

University of Wisconsin, Madison

Phase 2 Recruiting
8 enrolled
Breast

Breast Neoplasms, Neoplastic Cells, Circulating, Neoplasm Metastasis, Carcinoma, Lobular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡